Association between gain in adiposity and diabetic kidney disease worsening in type 2 diabetes is mediated by deteriorating glycaemic control: A 3-year follow-up analysis. (November 2019)
- Record Type:
- Journal Article
- Title:
- Association between gain in adiposity and diabetic kidney disease worsening in type 2 diabetes is mediated by deteriorating glycaemic control: A 3-year follow-up analysis. (November 2019)
- Main Title:
- Association between gain in adiposity and diabetic kidney disease worsening in type 2 diabetes is mediated by deteriorating glycaemic control: A 3-year follow-up analysis
- Authors:
- Moh, Angela Mei Chung
Wang, Jiexun
Tan, Clara
Ang, Su Fen
Ang, Keven
Subramaniam, Tavintharan
Sum, Chee Fang
Kwan, Pek Yee
Lee, Simon Biing Ming
Tang, Wern Ee
Lim, Su Chi - Abstract:
- Abstract: Aims: Increased adiposity confers elevated risk for diabetic kidney disease (DKD) progression in type 2 diabetes mellitus (T2DM). This 3-year prospective study examined whether worsening of metabolic control e.g. development of uncontrolled diabetes mediated the relationship between increased adiposity and DKD deterioration. Methods: T2DM subjects who had adequately controlled diabetes (HbA1c < 8%) at initial recruitment were analysed (N = 853). HbA1c ≥ 8% at follow-up was classified as development of uncontrolled T2DM. Absolute changes in body weight (ΔWeight), body mass index (ΔBMI), and body fat mass (ΔBFM) were calculated by subtracting baseline from follow-up values. DKD deterioration (outcome) was defined as an increase in the composite ranking of relative risk by glomerular filtration rate and albuminuria levels (Kidney Disease: Improving Global Outcomes 2009). Results: Subjects with deteriorated DKD displayed lower reduction in body composition at follow-up than those who remained stable or/improved (all P < 0.05). In separate regression models, ΔWeight (risk ratio (RR):1.04, 95% CI:1.01–1.06), ΔBMI (RR:1.07, 95% CI:1.01–1.13), and ΔBFM (RR:1.03, 95% CI:1.01–1.06) were independently associated with worsened DKD. The associations were attenuated after accounting for the loss of glycaemic control. Binary mediation analysis revealed that the development of uncontrolled diabetes explained 41.7%, 45.4% and 39.7%, respectively, of the effects of ΔWeight, ΔBMIAbstract: Aims: Increased adiposity confers elevated risk for diabetic kidney disease (DKD) progression in type 2 diabetes mellitus (T2DM). This 3-year prospective study examined whether worsening of metabolic control e.g. development of uncontrolled diabetes mediated the relationship between increased adiposity and DKD deterioration. Methods: T2DM subjects who had adequately controlled diabetes (HbA1c < 8%) at initial recruitment were analysed (N = 853). HbA1c ≥ 8% at follow-up was classified as development of uncontrolled T2DM. Absolute changes in body weight (ΔWeight), body mass index (ΔBMI), and body fat mass (ΔBFM) were calculated by subtracting baseline from follow-up values. DKD deterioration (outcome) was defined as an increase in the composite ranking of relative risk by glomerular filtration rate and albuminuria levels (Kidney Disease: Improving Global Outcomes 2009). Results: Subjects with deteriorated DKD displayed lower reduction in body composition at follow-up than those who remained stable or/improved (all P < 0.05). In separate regression models, ΔWeight (risk ratio (RR):1.04, 95% CI:1.01–1.06), ΔBMI (RR:1.07, 95% CI:1.01–1.13), and ΔBFM (RR:1.03, 95% CI:1.01–1.06) were independently associated with worsened DKD. The associations were attenuated after accounting for the loss of glycaemic control. Binary mediation analysis revealed that the development of uncontrolled diabetes explained 41.7%, 45.4% and 39.7%, respectively, of the effects of ΔWeight, ΔBMI and ΔBFM on the outcome. Conclusions: Among T2DM individuals who had adequately-controlled T2DM at initial recruitment, the relationship between gain in adiposity and DKD deterioration is mediated by the development of poor glycaemic control over time. Therefore, preventing worsening adiposity and hyperglycaemia is pivotal to impede DKD progression. … (more)
- Is Part Of:
- Diabetes research and clinical practice. Volume 157(2019)
- Journal:
- Diabetes research and clinical practice
- Issue:
- Volume 157(2019)
- Issue Display:
- Volume 157, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 157
- Issue:
- 2019
- Issue Sort Value:
- 2019-0157-2019-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-11
- Subjects:
- Type 2 diabetes mellitus -- Diabetic kidney disease -- Adiposity -- Hyperglycaemia
Diabetes -- Periodicals
Diabetes Mellitus -- Periodicals
616.462 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01688227 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01688227 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01688227 ↗
http://www.sciencedirect.com/science/journal/01688227 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.diabres.2019.107812 ↗
- Languages:
- English
- ISSNs:
- 0168-8227
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3579.603700
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12220.xml